This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Placebo Response in Psychotic Depression

Anthony J. Rothschild, MD

Published: December 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: I read with interest the report by Simpson et al.1 in theMay 2005 issue of the Journal. While it is always gratifyingto learn of the practical applications of one’s research,2,3 theauthors may be overinterpreting the significance of their openlabelobservations on the basis of a misconception of the placeboresponse in psychotic depression. The authors comparedtheir observations with 2 historical studies4,5 that found "a lowplacebo response rate with psychotic depression."1(p601)‘ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Assessment Methods , Research Methods Statistics

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...